Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163967 · ClinicalTrials.gov registry record · Phase 4
Effect of CES on Parasympathetic Tone
A Phase 4 study of Autonomic Nervous System Imbalance, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT02163967 is a Phase 4 study of Autonomic Nervous System Imbalance that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02163967, a Phase 4 study of Autonomic Nervous System Imbalance, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis is that CES stimulation will dose dependently increase parasympathetic tone. Healthy subjects will have three 20 minute sessions of CES stimulation, at three different intensities of stimulation, with each session occurring on a separate day. Effect on parasympathetic tone will determined by measuring high frequency heart rate variability before, during and after the stimulation. The Fisher Wallace Stimulator (FW100) which delivers a low dose alternating current a varying frequencies will be used for the stimulation.
Conditions Studied
Interventions
- DEVICE Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100)
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2013-01-11 |
| Est. Completion | 2013-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163967
The ClinicalTrials.gov registry entry for NCT02163967 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autonomic Nervous System Imbalance appearing as the primary indexed condition, and to 1 intervention - of which Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100) is the first listed.
NCT02163967 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02163967 about?
NCT02163967 is a clinical study titled "Effect of CES on Parasympathetic Tone". The hypothesis is that CES stimulation will dose dependently increase parasympathetic tone. Healthy subjects will have three 20 minute sessions of CES stimulation, at three different intensities of stimulation, with each session occurring on a separate day. Effect on parasympathetic tone will determ...
What is the current status of trial NCT02163967?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2013-01-11. Estimated completion is 2013-03-15.
What conditions does trial NCT02163967 study?
This clinical trial studies the following conditions: Autonomic Nervous System Imbalance.
What interventions are being tested in trial NCT02163967?
The interventions under investigation include: Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100) (DEVICE).
Who is sponsoring clinical trial NCT02163967?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02163967 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autonomic Nervous System Imbalance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.